Melatonin Prescribing in Children Rises 245% Over Nine Years: Trends and Concerns

Introduction:

Melatonin is increasingly being prescribed to children as a treatment for sleep disorders. While it can be an effective option in specific cases, experts warn that its growing use may indicate an over-reliance on medication rather than addressing underlying sleep issues. Recent figures show that the number of children receiving melatonin prescriptions has more than tripled in less than a decade, coinciding with a decline in prescriptions for other sleep treatments such as benzodiazepines and Z-drugs. This shift suggests a growing preference for melatonin in paediatric care, but also raises concerns about its long-term impact and appropriate usage.

Key Findings:

The analysis reveals a 245% increase in melatonin prescriptions for children, indicating a significant shift in how sleep disorders are managed. While melatonin is generally considered safer than other pharmacological sleep aids, experts caution against viewing it as a first-line treatment. Behavioural interventions, such as improving sleep hygiene and addressing lifestyle factors, should be prioritised before medication is introduced. Healthcare professionals emphasise that melatonin should only be used under medical supervision, particularly given the limited research on its long-term effects in children.

Implications for Clinical Practice:

The dramatic rise in melatonin prescribing highlights the need for greater awareness of non-pharmacological sleep interventions. Healthcare providers should ensure that parents are educated on sleep hygiene strategies, such as maintaining consistent bedtime routines, limiting screen time before sleep, and creating a calm sleep environment. Additionally, clinicians should assess whether underlying conditions, such as anxiety or ADHD, may be contributing to sleep disturbances before resorting to melatonin prescriptions. A more holistic approach to paediatric sleep health can help reduce unnecessary reliance on medication.

Conclusion:

While melatonin can play a role in managing paediatric sleep disorders, its increasing use raises concerns about overprescription and long-term effects. The 245% rise in prescriptions over nine years underscores the need for a balanced approach, ensuring that behavioural and environmental factors are addressed before medication is considered. Healthcare providers, parents, and policymakers must work together to promote evidence-based sleep management strategies, prioritising non-pharmacological interventions wherever possible.

Read more: Melatonin prescribing in children rises by 245% in nine years, data show